价格

MYLAN PHARMACEUTICALS PRIVATE LIMITED

Mylan Pharmaceuticals Pvt Ltd, Plot No A-6 and A-7, C/o Shree, Patna, Bihar, 印度

别名:

mylan pharmaceuticals limited

概览

试验阶段分布

阶段

试验数

占比

不适用

40.0%

3 期

20.0%

试验状态分布

已完成

80.0%

招募中

20.0%

药物批准

按机构分类的批准

EMA

European Medicines Agency

药物批准

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

药物批准

近期批准

TADALAFILO MYLAN 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

CIMA_AEMPS

2024-09-23

TADALAFILO MYLAN 10 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG

CIMA_AEMPS

2024-09-23

Sitagliptin / Metformin hydrochloride Mylan

资讯

暂无资讯文章

返回机构列表

MYLAN PHARMACEUTICALS PRIVATE LIMITED

概览

试验阶段分布

试验状态分布

相关临床试验

该机构主办的试验（5）

The study to evaluate the effectiveness and safety of ElidelÂ® in small children/babies affected by mild to moderate Atopic dermatitis (AD) in India

A Bioequivalence Study Using Clinical Endpoint for Diclofenac Sodium Gel 1% in Osteoarthritis Knee"

To study Mucormycosis epidemiology in India

To study Mucormycosis epidemiology in India

The study to evaluate the effectiveness and safety of Elidel® in small children/babies affected by mild to moderate Atopic dermatitis (AD) in India

药物批准

按机构分类的批准

近期批准

资讯